Clinical Trial Update: A Phase I/II Study of MEDI4736 in Combination With Olaparib in Patients With Advanced Solid Tumors. [Phase 1, Phase 2]

View source ↗

Summary

A Phase I/II study evaluating atezolizumab in combination with olaparib in patients with advanced solid tumors, including ovarian, breast, small cell lung cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Gastric Cancer
• Ovarian Cancer
• Small Cell Lung Cancer

Drugs mentioned

• Lynparza (olaparib)
• Tecentriq (atezolizumab)

Snippet

Sponsor: AstraZeneca | Conditions: Ovarian, Breast | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2023-10-13